We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Phorm Corp | PHRM | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 1.00 | 01:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 1.00 | 1.00 |
| Top Posts |
|---|
Posted at 18/3/2017 21:42 by bluecar1 just checking in to ensure still dead, and still no sign of all the ash from the incinerated investor cash |
Posted at 31/5/2016 18:52 by btcustomer For example, can I ask ...Is Phorm Inc still trading? Forget Phuid Media UK etc etc Is imarker still part of the interweb? and/or Phorm? What was/is insomnis? What, if anything, are insomnis.com doing these days? Where are/were they based? Do you mean Phorm Inc or Phorm Corporation (Singapore) Ltd? PhormUK Inc became PhluidMedia Inc. and the registration is still active at Companies House. Phorm Inc is probably still around in Delaware somewhere. Phorm Corporation? - you'd have to apply to the Singapore authorities to find out about the company status and nowadays the company registrar makes you pay for the info. Imarker - still has a web presence and appears to still be active. No idea who owns it - there was never any clarity about that. Insomnis Media - Appeared magically around the time Phorm Corporation were trying to raise funds in the USA, and possibly created an impression that Phorm had "media partners" - which some gullible investors may have been taken in by. Website still around, UK Companies house registration still active. hxxp://www.insomnis- hxxp://www.imarker.c shows: Entity Name : PHORM CORPORATION LIMITED(n.k.a) PHORM CORPORATION PTE. LIMITED(f.k.a) shown as "live company". but with a RED CROSS for compliance rating - ie NON COMPLIANT The State of Delaware lists: Phorm Acquisition Corp 4308842 Phorm Inc 4308840 Phorm Redom Corp 5194342 Enjoy. I imagine things will remain completely murky for quite some time. |
Posted at 11/5/2016 20:08 by btcustomer Is Andy Pipkin still here? How sad!(PS He's still as uninformed as ever - Phorm aren't bust - just in very deep trouble, with their shares suspended and no obvious means of support.) Phluid Media Inc. are still listed as trading/active at Companies House UK. LSE De-listing of PHRM shares is tomorrow or Monday. But the last stinking dying breath of Phorm Corporation (Singapore) Ltd? We await that with "tremendous excitement". But Phorm's collapse won't be a "surprise to us, to be honest". (to paraphrase Ertugrul) A reminder of corporate mendacity at its worst: (why gullible idiots believed this Phorm RNS stuff, I do not know) 6 July 2009 As regards our UK deployment, Phorm's activities remain ongoing and we look forward to creating the conditions necessary for UK ISPs to move to deployment. In parallel, we continue to focus considerable effort on faster moving overseas opportunities. In so doing we have already minimised our dependency on the deployment by any single ISP or in any particular market. In addition to making excellent progress in South Korea, we are engaged in more than 15 markets worldwide including advanced negotiations with several major ISPs. These discussions have been greatly accelerated by the launch of Webwise Discover and its clear benefit to consumers, which has been viewed as a key step forward by all of our partners, including those in the UK. We remain very confident in our ability to deliver on the promise of this substantial opportunity. I'm not sure I can find a single "truth" in those two paragraphs. But the money just kept rolling in. 26 days earlier he had charmed £15m out of a range of gullible investors, presumably with a completely different set of predictions. Korea Markets Update never did arrive... What a stench! |
Posted at 16/4/2016 20:03 by bluecar1 Soul Limbo 15 Apr'16 - 12:46 - 51357 of 51359how did they manage to extract over $317m from investors over the years is just mind boggling. All for nought. how did they manage to extract money from? , simple, think of the old adage "a fool and their money are easilly parted", also very few investors where gambling their own money but clients who trusted them to make good investments on their behalf (even if in high risk funds) so many investors seemed to have believed the spiel from the "management team" everytime they entered a new market, some of them appeared to have been "in" from the start and didn't seem to learn, others seem to swallow hook line and sinker to the bitter end and if you look back over the life of phorm since the BT trials, myself, BTC, felix etc have said their was isuues with the tech and the amount of cash burn needed a massive revenue stream to support it which they never managed to get more than a few percent of, so little chance of success and that is from a non investor just using common sense and looking at the legal issues the biggest question is where did all the money go? most years the largest chunk of money seemed to go to R&D, so whoever ran that must be unhappy the gravy train just hit the buffers? |
Posted at 18/2/2016 17:39 by btcustomer Four working days left for Phorm to sell £2.5m worth of shares to gullible investors - and at the present SP, that means disposing of a further 232.55m shares - around 23% more shares in issue.At these prices, the most interesting stuff is not Phorm's abysmal cash flow or pathetic revenues - it's the story of who is bending which investors' arm up behind which shareholders' backs, and who ends up either controlling the company, or which non-controlling interest can demand a takeover offer be made, and which of them can threaten bankruptcy with whatever leverage they have under various stock exchange rules about takeover and control. It becomes important because of the sheer volume of new shares being issued for such small amounts of money - and another $8m worth of shares have to be issued during 2016 AFTER 24th Feb, unless revenues show miraculous growth to commercially useful levels (ie. the sort that pays the bills). And is there anything worth buying anyway, given the apparent lack of patented technology, and the fact that a bankrupted company's workforce will work for the highest bidder. It would be truly ironic if the story of Phorm ended up mirroring the story of how control of iMarker was wrested from the grip of Mikhail Berlizev in May - July 2014 ( Twitter - @mberlizev ) because the original team left iMarker when that takeover occurred and Phorm had to put in new people. Although strangely they never announced anything about the Russian asset to Phorm's shareholders or prospective investors... - maybe they were embarrassed at only earning R44.7m during H1 2015 (£409k/$589k at today's rates - not even enough to cover the Golden Boot payments!) from their newly acquired existing Russian business. Those were the only revenues we heard about in the July 2015 operational update - what a let-down from the Bigger predictions of $7m for that half-year's revenues which he had made only six months earlier on management advice. Weren't Phorm telling us that with their new ad-tech model, there would no longer be delays on entering new markets, before the revenues started coming in? Or was that another thing they got wrong in their January operational update last year? (around the time Bigger was publishing his latest information about projected 2015 revenues) Revenue is currently anticipated to build rapidly with prices and margins increasing following the international New Year holiday periods. Large commercial campaigns have now been allocated in budgets for 2015. and again in the June 2015 annual financial report for 2014? Commercial operations started in the US in late April 2015, with a series of test campaigns. The initial results from these campaigns have been most encouraging such that, within a matter of just a few weeks, the first test campaigns have been successfully converted to revenue generating commercial campaigns. These initial results strongly indicate that we should be able to comfortably meet the demands of the US market and we currently expect commercial revenues from the US to grow rapidly in 2015. Oh dear - instead we got a failed funding (not the first either), a £2.5m bailout and a predicted cash requirement for 2016 of a further $8m. What happened to all those revenue predictions then? Was someone telling porkies? They didn't get the revenue did they? - just the bailout cash - the only sort they seem to be able to find. |
Posted at 17/2/2016 13:08 by btcustomer Investors' day off ?Taking a breath before the next collapse? (Or maybe that flat line means the patient is dead?) Gullible investors urgently needed - £2.5m pounds worth of penny shares for sale. |
Posted at 16/2/2016 17:14 by btcustomer I think it''s investors who are taking time off - which is a problem, as Phorm need to find gullible investors to buy £2.5m worth of new shares within the next 8 days, and then even more gullible investors to cough up a further $8m before the end of the year.With cash levels at around MINUS $1.9m at the moment, and the extra expense of loan interest and arrangement fees, Phorm have quite a challenge to meet - especially as their revenue is clearly well below target levels. With the price at 1.125p, that will require the sale of an awful lot of shares, 222.2m shares for the first £2.5m and then a further 600m shares during 2016. There will be 2 billion shares in issue by the end of the year unless something changes very soon in terms of revenues. Anyone seen the H23 2015 revenue figures or are Phorm still too scared to talk about those? I'd love to know how they are selling their product, now that they don't have DPI as a unique selling point, but are flogging just another algorithm (with added hovver-bovver) like all the other ad-tech companies trying to defeat adblockers. What happened to the zoom? |
Posted at 09/2/2016 08:08 by btcustomer 15 days left to raise £2.5m (pounds) from gullible investors after failure to raise $1m on 18th Jan, substituting 6% loans and emergency $1/2m bailouts from existing investors. Share price at all-time low.New diluting bailout shares due to arrive on market tomorrow taking numbers over a billion again. DYOR. This company is very unwell. Revenues? Phorm don't like talking about revenues. |
Posted at 04/2/2016 23:36 by btcustomer So the subscription from 18th Jan FAILED - and the undertakings given by the mysterious sole US investor both then and prior to 1st Feb were worthless - so the lawyers are now charging fees to try and suck out the money. I bet THEY don't get paid in shares!So those with money already sunk into the company, have had to cough up more cash and more loans and convert the earlier loans into yet more shares - otherwise their existing investments of millions of dollars would have evaporated in a bankruptcy. And now we await for the next begging bowl round - £2.5m POUNDS to be raised for more shares, by 24th Feb. I wonder who is going to cough up? Perhaps they need to include some thumb screws in the begging bowl kit? Are there enough gullible investors out there who haven't yet heard of Phorm and who won't expect awkward things like being told the full story of Phorm's inability to earn revenues, or why their R&D cost is so high year after year? On 10th Feb, shares in issue will be 1,050,777,150 - even with the withdrawl of the Jan 18th shares - the dilution continues and continues past the billion mark. And the investors are harder to find each time, and cough up less cash when they are found (or fail to cough up). The only currency Phorm seems to be able to spend is the currency of its own shares, which it prints relentlessly to solve every problem. I do have some questions which I know won't be answered. What on earth went wrong with the Jan 18th subscription? Who WAS this un-named sole US investor who Phorm are now having to sue? Did they even exist? What happened to that investment? Did the investor suddenly run out of money? Did they suddenly discover something they didn't know before? Was this a GENUINE share subscription? Or has something odd happened - to produce the rather convenient and pressurised circumstances where existing investors have been virtually FORCED to cough up loans and further investment, and provide yet another short term cash solution to Phorm's chronic inability to earn revenue, or else sit back and watch the company collapse and their entire shareholding become worthless. It rather reminds me of the missing China £20m share subscription back on the 1st June 2012 There was lots of hype about the potential of China at the time, even UKTI were dragged into the shouting game, and Phorm's share price went up dramatically - doubling from around 65p to 130p on the back of the announcements and undertakings on China, and the news of that £20m fundraise that never was. Then of course the whole thing folded and the money floated away across the China sea like 20m paper lanterns at a Chinese New Year festival, and the share price plummetted from 130p way down below the original 65p level after the announcement of failure in September 2012 - and eventually, we heard about "operational challenges" in China - and of course - the revenue never ever appeared and the supposed search for alternative sources of funding was abandoned. What on earth is going on, and isn't it time someone had a really good look at the finances and behaviour of this company over the last ten years, including the last few months - under the old board AND the new board? Or is this just what we have to put up with on the AIM cesspit? There sure is a very nasty smell. I think they are reasonable questions. I doubt anyone will provide an answer. |
Posted at 05/10/2015 16:19 by btcustomer IgbertSponk - you really need to put up or shut up on this Google smear. What proof have you got? None.Phorm appears to have dropped off the horizon for investors. You'd have thought the interims 6 days ago, would have sparked some interest - maybe astute investors were put off by the abysmal revenue performance, or perhaps they did some due diligence on Insomnis Media Ltd? Maybe they don't believe Mr Bigger anymore? Maybe they've lost faith in superheroes? Maybe they don't like the "send data to Russia" trading model? Maybe they are shocked at how poorly the main backers seem to understand the tech? Maybe they wonder whether Mr Ertugrul is still beavering away at Phorm China Ltd. and they can't see why all that investorcash is being spent on the Golden Boot payment? (Last instalment due in 10 days). Maybe they just don't undertand why Phorm are still trading, now that the $2.4m cash available on 31st August, has had to last beyond the end of September, when cash burn is stated to be $2.5m per month? Not even the stupid investors seem to be stirring today. Maybe this had an effect? (market cap today - £43m, total losses since 2003, $395m, directors emoluments since 2003, $13.4m, available cash MINUS $0.57m) Lots of reasons NOT to invest in Phorm - all of them bang up to date. And not a single share moving today. Oh dear. |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
